Modification of Cardiovascular Proteins by Metabolic Disease
A wide variety of academic faculty members combined to create the Cardiovascular Proteomics Center under the direction of Dr. Catherine E. Costello. CPC is a research institute studying oxidative stress using proteomics technologies. The faculty, true to the multi-disciplinary nature of cross-university alliances (which are spurring BUSM research grants in an era of restricted growth in biomedical research), represent the schools/departments/sections of Biochemistry, Physiology and Biophysics, Mass Spectrometry, Engineering, Bioinformatics, Cardiology, Epidemiology, and Medicine. In addition, CPC has many relationships and ongoing projects with researchers in the corporate sector.
|Catherine E. Costello, Ph.D.||Principal Investigator||Mass Spectrometry, Proteomics Methods, Unfavorable Metabolic Syndromes|
|Richard A. Cohen, M.D.||Co-PI, Leader for Vascular Biology Project||Methods for Mouse Studies|
|Wilson S. Colucci, M.D.||Co-PI, Leader for Clinical Project||Metabolic Predictors of Diastolic Heart Failure|
|Mark E. McComb, Ph.D.||Director, Cardiovascular Proteomics Core Laboratory||Development and application of mass spectrometry (MS) and proteomics based technologies for the characterization of human disease|
|Vasan S. Ramachadran, M.D.||Collaborator, BUSM, Framingham Heart Study||Observations in the Offspring Cohort of the Framingham Heart Study|
|Christian Schöneich, Ph.D.||Chair, Dept. of Pharmaceutical Chemistry, U Kansas||Mechanisms of free radical reactions and protein stability|